Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...

In a welcome move, Bristol Myers Squibb saw its Relative Strength Rating improve from 70 to 76 on Tuesday. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental ...

David Risinger, an analyst from Leerink Partners, maintained the Hold rating on Bristol-Myers Squibb (BMY – Research Report). The associated price target was raised to $55.00. David Risinger has given ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ... CEO of the Alliance for ...

By Michael Erman (Reuters) -Bristol Myers Squibb reported a higher-than-expected third-quarter profit on Thursday, citing ...

In my seventh year as a deals editor during Prime Day, it came as no surprise to see that Amazon's own devices got some of the biggest discounts over the last two days. All of these are no longer ...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In this segment, Dr. Roxanna Mehran of the Mount Sinai Health System is talking about the Bristol-Myers Squibb-Janssen Librexia Clinical Trial Program. More information on the clinical trial and ...

Israel’s government says a drone was launched toward the the prime minister’s house Saturday, with no casualties JERUSALEM -- Israel’s government says a drone was launched toward the the ...